Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Vanda Pharmaceuticals Inc. (VNDA) A Good Stock To Buy?

Insider Monkey has processed numerous 13F filings of hedge funds and famous investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds’ and investors’ positions as of the end of the fourth quarter. You can find write-ups about an individual hedge fund’s trades on numerous financial news websites. However, in this article we will take a look at their collective moves and analyze what the smart money thinks of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) based on that data.

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) was in 19 hedge funds’ portfolios at the end of December. VNDA shareholders have witnessed a decrease in hedge fund interest of late. There were 20 hedge funds in our database with VNDA holdings at the end of the previous quarter. Our calculations also showed that VNDA isn’t among the 30 most popular stocks among hedge funds.

At the moment there are plenty of gauges stock traders use to value stocks. A pair of the less utilized gauges are hedge fund and insider trading moves. Our experts have shown that, historically, those who follow the top picks of the best hedge fund managers can outperform the S&P 500 by a solid margin (see the details here).

Brad Farber Atika Capital

We’re going to check out the new hedge fund action regarding Vanda Pharmaceuticals Inc. (NASDAQ:VNDA).

Hedge fund activity in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)

At the end of the fourth quarter, a total of 19 of the hedge funds tracked by Insider Monkey were long this stock, a change of -5% from the previous quarter. Below, you can check out the change in hedge fund sentiment towards VNDA over the last 14 quarters. With the smart money’s sentiment swirling, there exists a few key hedge fund managers who were boosting their stakes considerably (or already accumulated large positions).


The largest stake in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) was held by Consonance Capital Management, which reported holding $121.7 million worth of stock at the end of December. It was followed by Palo Alto Investors with a $108.6 million position. Other investors bullish on the company included Renaissance Technologies, Adage Capital Management, and Millennium Management.

Seeing as Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) has faced falling interest from the entirety of the hedge funds we track, logic holds that there exists a select few funds that elected to cut their entire stakes in the third quarter. It’s worth mentioning that Steven Boyd’s Armistice Capital said goodbye to the largest investment of the 700 funds monitored by Insider Monkey, worth an estimated $20.7 million in stock. Behzad Aghazadeh’s fund, venBio Select Advisor, also cut its stock, about $9.9 million worth. These transactions are important to note, as aggregate hedge fund interest was cut by 1 funds in the third quarter.

Let’s go over hedge fund activity in other stocks – not necessarily in the same industry as Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) but similarly valued. These stocks are Fresh Del Monte Produce Inc (NYSE:FDP), Matson, Inc. (NYSE:MATX), Kulicke and Soffa Industries Inc. (NASDAQ:KLIC), and Shutterfly, Inc. (NASDAQ:SFLY). This group of stocks’ market caps match VNDA’s market cap.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
FDP 15 42866 1
MATX 12 17426 3
KLIC 19 243689 -3
SFLY 22 367739 -1
Average 17 167930 0

View table here if you experience formatting issues.

As you can see these stocks had an average of 17 hedge funds with bullish positions and the average amount invested in these stocks was $168 million. That figure was $377 million in VNDA’s case. Shutterfly, Inc. (NASDAQ:SFLY) is the most popular stock in this table. On the other hand Matson, Inc. (NYSE:MATX) is the least popular one with only 12 bullish hedge fund positions. Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) is not the most popular stock in this group but hedge fund interest is still above average. This is a slightly positive signal but we’d rather spend our time researching stocks that hedge funds are piling on. Our calculations showed that top 15 most popular stocks) among hedge funds returned 24.2% through April 22nd and outperformed the S&P 500 ETF (SPY) by more than 7 percentage points. Unfortunately VNDA wasn’t nearly as popular as these 15 stock and hedge funds that were betting on VNDA were disappointed as the stock returned -35.7% and underperformed the market. If you are interested in investing in large cap stocks with huge upside potential, you should check out the top 15 most popular stocks) among hedge funds as 13 of these stocks already outperformed the market this year.

Disclosure: None. This article was originally published at Insider Monkey.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.